ScoreWhy is Teyi Pharmaceutical Group Co., Ltd. ?
1
With a growth in Net Profit of 719.47%, the company declared Outstanding results in Sep 25
- PRE-TAX PROFIT(Q) At CNY 26.78 MM has Grown at 2,337.66%
- NET PROFIT(Q) At CNY 27.21 MM has Grown at 719.47%
- INTEREST COVERAGE RATIO(Q) Highest at 3,802.33
2
With ROE of 3.15%, it has a fair valuation with a 2.47 Price to Book Value
- Over the past year, while the stock has generated a return of 23.07%, its profits have fallen by -51.6%
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Teyi Pharmaceutical Group Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Teyi Pharmaceutical Group Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Teyi Pharmaceutical Group Co., Ltd.
27.78%
0.54
46.02%
China Shanghai Composite
13.33%
0.90
14.74%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
6.82%
EBIT Growth (5y)
-4.64%
EBIT to Interest (avg)
8.54
Debt to EBITDA (avg)
0.88
Net Debt to Equity (avg)
-0.01
Sales to Capital Employed (avg)
0.41
Tax Ratio
14.65%
Dividend Payout Ratio
121.95%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
9.69%
ROE (avg)
9.04%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
78
Industry P/E
Price to Book Value
2.47
EV to EBIT
68.52
EV to EBITDA
33.31
EV to Capital Employed
2.50
EV to Sales
5.08
PEG Ratio
NA
Dividend Yield
0.37%
ROCE (Latest)
3.64%
ROE (Latest)
3.15%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
No Trend
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend25What is working for the Company
PRE-TAX PROFIT(Q)
At CNY 26.78 MM has Grown at 2,337.66%
NET PROFIT(Q)
At CNY 27.21 MM has Grown at 719.47%
INTEREST COVERAGE RATIO(Q)
Highest at 3,802.33
RAW MATERIAL COST(Y)
Fallen by -53.94% (YoY
NET SALES(Q)
At CNY 200.71 MM has Grown at 41.49%
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Here's what is working for Teyi Pharmaceutical Group Co., Ltd.
Pre-Tax Profit
At CNY 26.78 MM has Grown at 2,337.66%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (CNY MM)
Net Profit
At CNY 27.21 MM has Grown at 719.47%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very positive
Net Profit (CNY MM)
Interest Coverage Ratio
Highest at 3,802.33
in the last five periodsMOJO Watch
The company's ability to manage interest payments is improving
Operating Profit to Interest
Net Sales
At CNY 200.71 MM has Grown at 41.49%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Raw Material Cost
Fallen by -53.94% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
